MANGROVE PARTNERS IM, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 103 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
MANGROVE PARTNERS IM, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$8,892,000
-2.3%
1,092,394
+15.2%
1.12%
-49.4%
Q2 2020$9,099,000
+95.7%
947,852
+38.6%
2.22%
+246.5%
Q1 2020$4,650,000
-63.2%
683,828
-19.3%
0.64%
-65.3%
Q4 2019$12,625,000
+45.4%
847,2840.0%1.85%
+75.7%
Q3 2019$8,685,000
-3.3%
847,2840.0%1.05%
+3.6%
Q2 2019$8,981,000
+17.4%
847,284
+54.8%
1.02%
-0.8%
Q1 2019$7,651,000
+37.6%
547,2840.0%1.02%
+38.1%
Q4 2018$5,560,000547,2840.74%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders